MedPath

The survey of Magnesium Sulfate in Prevention of Intraventricular Hemorrhage in Premature Infants

Phase 2
Conditions
Premature Infants.
Fetus and newborn affected by premature rupture of membranes
Registration Number
IRCT2016080729223N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

who are have signed a consent form; Gestational age 34 weeks; Lack of Hypertension; Lack of Pre-eclampsia; Lack of congenital malformations.
Exclusion criteria: Lack of consent for enter the study; having hypertension; having pre-eclampsia; having congenital malformations.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath